Transcatheter Closure of Atrial and Ventricular Septal Defects: JACC Focus Seminar.
atrial septal defect
congenital heart disease
interventional cardiology
transcatheter device closure
ventricular septal defect
Journal
Journal of the American College of Cardiology
ISSN: 1558-3597
Titre abrégé: J Am Coll Cardiol
Pays: United States
ID NLM: 8301365
Informations de publication
Date de publication:
07 06 2022
07 06 2022
Historique:
received:
03
03
2021
revised:
02
08
2021
accepted:
09
08
2021
entrez:
2
6
2022
pubmed:
3
6
2022
medline:
7
6
2022
Statut:
ppublish
Résumé
The field of congenital interventional cardiology has experienced tremendous growth in recent years. Beginning with the development of early devices for transcatheter closure of septal defects in the 1970s and 1980s, such technologies have evolved to become a mainstay of treatment for many atrial septal defects (ASDs) and ventricular septal defects (VSDs). Percutaneous device closure is now the preferred approach for the majority of secundum ASDs. It is also a viable treatment option for selected VSDs, though limitations still exist. In this review, the authors describe the current state of transcatheter closure of ASDs and VSDs in children and adults, including patient selection, procedural approach, and outcomes. Potential areas for future evolution and innovation are also discussed.
Identifiants
pubmed: 35654496
pii: S0735-1097(22)04681-2
doi: 10.1016/j.jacc.2021.08.082
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2247-2258Informations de copyright
Copyright © 2022 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Funding Support and Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose.